Shanghai GenTech Co Ltd (688596) fair value: what the stock is really worth
As of Sep 30, 2026: fair value of Shanghai GenTech Co Ltd ¥9.73, price ¥57.93, upside -83.2%, quality 25 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
Watch Shanghai GenTech Co Ltd for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card.Watch for freePro now: $1 first month
Shanghai GenTech Co., Ltd. provides process critical system solutions in China and internationally.
Show more
Shanghai GenTech Co., Ltd. provides process critical system solutions in China and internationally. The company offers high purity gas delivery equipment, high purity chemical delivery equipment, slurry mixing and delivery system, process equipment, high-purity media equipment system integration, customized equipment, and clean fluid system; and equipment and system integration process services, including design, manufacturing, and installation for IC, flat panel displays, solar photovoltaics, LED, fiber optics, and bio-pharmaceutics. It also provides high purity electronic materials used in silicon wafer epitaxial growth, solar photovoltaic cells, LED lighting, flat panel display, IC and other industries. In addition, the company offers maintenance, repair, and operation services; and regeneration and recycling solutions. Shanghai GenTech Co., Ltd. was founded in 2009 and is headquartered in Shanghai, China.
Stock analysis
Shanghai GenTech Co Ltd (688596) currently trades at ¥57.93, while our model-based Fair Value estimate is ¥9.73, 83.2% below the price, so the stock looks overvalued today.
Show more
Valuation
Bull case: the Growth Earnings group reads highest at a median of ¥15.74 per share, and 0 of the 14 models we run sit above the ¥57.93 price.
Bear case: the Dividend Discount group reads lowest at ¥5.44, and 14 of the 14 models stay below the price. Evidence for this calculation is low.
Quality & growth
The Quality Score stands at 25/100 (below-average quality), in the Industrials sector.
Expensive Growth: The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Shanghai GenTech Co Ltd reported revenue of 4.9B CNY in FY2025 versus 1.8B CNY in FY2021, a compound +27.9%/yr. Reported net income was 138M CNY in FY2025, compounding −4.9%/yr from FY2021.
Key figures
Market cap 21.7B CNY (≈ $3.2B) · P/E ratio 214.6 · P/S ratio 6.02 · EPS (TTM) ¥0.2700 · Dividend yield 0.2% · Net margin 2.8% · Return on equity 2.0% · Return on assets (EBIT) 4.5%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 38 out of 100 (medium confidence).
What moves the price
The share trades about 31% below its 52-week high and 110% above its 52-week low, currently above its 200-day average.
For context, the median of 10 Industrials peers we cover trades at −49% fair-value upside, at −83%, 688596 screens richer than that median.
Fair Value models
The price assumes far more growth than our models allow for, so the models scatter widely (¥1.05 to ¥21.13). Read the Fair Value as a cautious anchor, not a price target; the Growth Forecast section shows what the price assumes.
Bear ¥9.73Fair Value ¥9.73Bull ¥9.73
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Based on fiscal year 2025 figures (about 9 months old). Earnings retained since then (¥0.1285 per share) are deliberately not added.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.52/100
The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Revenue growth 1 year
−10.0%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+22.1%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+34.7%
Start year 2020 (pandemic). Over 10 years: +25.4% a year
Revenue growth 12 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+29.8%
’14
’15
’16
’17
’18
’19
’20
’21
’22
’23
’24
’25
What shareholders gained per year (last 5 years) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate.
−3.5%
Earnings growth per share plus dividend.
Earnings per share, growth per year−3.7%
Dividend (yield on the price)0.2%
Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.−3.7% vs 13.1%, slowing
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.13% → 2%
Compare Shanghai GenTech Co Ltd with another stock
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Specialty Industrial Machinery · 789 stocks
Beats the industry median on 1/13 measures
Overall it trails its industry peers.
Valuation
Quality Score25 · Bottom 25%
Fair Value upside−83.2% · Bottom 25%
Profitability
Return on equity (TTM)2.0% · Below median
Return on assets0.6% · Below median
Net margin (TTM)1.5% · Below median
Operating margin (TTM)2.0% · Below median
Growth and dividend
Revenue growth43.4% · Top 25%
Dividend yield (TTM)0.2% · Bottom 25%
Balance sheet
Debt / equity0.55× · Highest 25%
Valuation Multiplesvs Specialty Industrial Machinery median · lower = cheaper
P/E (TTM)214.6× · Priciest 25%
P/B5.36× · Priciest 25%
P/S (TTM)4.16× · Priciest 25%
EV/EBITDA79.3× · Priciest 25%
Strength profile in five axes (Snowflake)
This stockSector peers
VALUE (fair-value potential)0· sector 0
FUTURE (revenue growth)100· sector 30
PAST (return on equity)8· sector 28
HEALTH (low debt)72· sector 96
DIVIDEND (yield)3· sector 26
VALUE 0: the price sits above our fair-value range.
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "Shanghai GenTech Co Ltd Fair Value". https://www.fairvalue-calculator.com/stock/688596
Frequently asked questions
Is Shanghai GenTech Co Ltd (688596) overvalued or undervalued?
As of Sep 24, 2026, our model estimates a fair value of ¥9.73 versus a price of ¥57.93, about −83% upside (overvalued).
What is the fair value of 688596?
Our model-based fair value for Shanghai GenTech Co Ltd is ¥9.73 (as of Sep 24, 2026), built from audited fundamentals. The current price: ¥57.93.
What is the quality score of 688596?
Shanghai GenTech Co Ltd has a Quality Score of 25/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Shanghai GenTech Co Ltd (688596)?
Our model-based price target is the fair value of ¥9.73 (as of Sep 24, 2026) from 16 valuation models. It is a calculation from audited fundamentals, not an analyst target.
What is the Shanghai GenTech Co Ltd stock forecast for 2026?
Our models put fair value at ¥9.73, about −83% upside versus a price of ¥57.93 (overvalued). The calculation is refreshed regularly with new filings.
What is the revenue of Shanghai GenTech Co Ltd (688596)?
Shanghai GenTech Co Ltd reported trailing-twelve-month revenue of about 5.2B CNY (latest available figure, as of Sep 24, 2026).
Does Shanghai GenTech Co Ltd pay a dividend?
Shanghai GenTech Co Ltd currently shows a dividend yield of about 0.17% relative to its recent price (as of Sep 24, 2026).
What is the intrinsic value of Shanghai GenTech Co Ltd (688596)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Shanghai GenTech Co Ltd it is ¥9.73 per share (as of Sep 24, 2026), against a price of ¥57.93. It is the blended result of 16 valuation models (cash flow, earnings, asset, dividend).
Is Shanghai GenTech Co Ltd stock overvalued or undervalued in 2026?
As of Sep 24, 2026, 688596 trades above its calculated fair value: price ¥57.93, fair value ¥9.73, a gap of about −83% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 688596?
No. The price is what the market pays today (¥57.93); the fair value is what the company's own numbers justify (¥9.73). For Shanghai GenTech Co Ltd the two are ¥48.20 per share apart. That gap is exactly why we show both numbers side by side.
How much is Shanghai GenTech Co Ltd worth?
The market values Shanghai GenTech Co Ltd at about 21.7B CNY (market capitalisation, as of Sep 24, 2026). Per share that is ¥57.93; our models calculate a fair value of ¥9.73 per share.
What is the P/E ratio of 688596?
Shanghai GenTech Co Ltd trades at a price-to-earnings ratio of 214.6 (as of Sep 24, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of ¥9.73 is built from several models across several years. Other multiples: P/B 5.4, P/S 4.2, EV/EBITDA 79.3.
How solid is the balance sheet of Shanghai GenTech Co Ltd (688596)?
Balance-sheet figures for Shanghai GenTech Co Ltd (as of Sep 24, 2026): return on equity 2.0%, debt of 0.55 per unit of equity. They feed the Quality Score of 25/100, which measures business quality independently of the share price.
How far is 688596 from its 52-week high?
Shanghai GenTech Co Ltd trades at ¥57.93, about 31% below its 52-week high of ¥83.66 and 110% above the low of ¥27.59 (as of Sep 30, 2026). Distance from the high says nothing about value: that is what the fair value of ¥9.73 is for.
Which stocks are comparable to Shanghai GenTech Co Ltd?
From the same area (Industrials) we also value GE Vernova Inc, SIE, Eaton Corporation, Parker-Hannifin Corporation, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Shanghai GenTech Co Ltd stock attractive at the current price?
The data as of Sep 24, 2026: price ¥57.93, calculated fair value ¥9.73 (−83%), Quality Score 25/100, from 16 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 688596 calculated?
We run Shanghai GenTech Co Ltd through 16 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of ¥9.73, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.5 % above its aggregate fair value. Shanghai GenTech Co Ltd itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Shanghai GenTech Co Ltd (688596)?
The closing price on Sep 30, 2026 was ¥57.93. Our model-based fair value is ¥9.73, about −83% upside (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Shanghai GenTech Co Ltd right now?
The price sits above even our optimistic bull case (¥9.73). The favourable scenario is already priced in. Weak quality (25/100) and above fair value at the same time, the margin of safety is missing on both counts. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution.
Where does the earnings growth of Shanghai GenTech Co Ltd (688596) come from?
Earnings per share at Shanghai GenTech Co Ltd grew +30.0 % a year from 2014 to 2025. Broken into its drivers: revenue per share +18.0 %, EBIT margin +10.8 %, tax rate +2.0 %, residual (interest, one-offs) −2.5 %. The four rates multiply to the earnings growth rate, they do not add up. Start and end are three-year averages so a single exceptional year does not distort the result.
Key figures of Shanghai GenTech Co Ltd
How large is the market capitalisation of Shanghai GenTech Co Ltd (688596)?
The market capitalisation of Shanghai GenTech Co Ltd is 21.7B CNY (≈ $3.2B). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Shanghai GenTech Co Ltd (688596)?
The price-to-sales ratio of Shanghai GenTech Co Ltd is 6.02 (P/E × margin). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Shanghai GenTech Co Ltd (688596)?
Earnings per share at Shanghai GenTech Co Ltd are ¥0.2700 (price ÷ EPS = P/E 214.6). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Shanghai GenTech Co Ltd (688596)?
The dividend yield of Shanghai GenTech Co Ltd is 0.2% (payout 37.0%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Shanghai GenTech Co Ltd (688596)?
The net margin of Shanghai GenTech Co Ltd is 2.8% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Shanghai GenTech Co Ltd (688596)?
The return on equity (ROE) of Shanghai GenTech Co Ltd is 2.0% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Shanghai GenTech Co Ltd (688596)?
On an EBIT basis the return on assets of Shanghai GenTech Co Ltd is 4.5% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Shanghai GenTech Co Ltd (688596)?
The operating margin of Shanghai GenTech Co Ltd is 2.0% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Shanghai GenTech Co Ltd (688596)?
Revenue at Shanghai GenTech Co Ltd is growing +43.4% versus a year earlier (3y avg +22.1%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Shanghai GenTech Co Ltd (688596)?
Earnings per share at Shanghai GenTech Co Ltd are growing −66.9% versus a year earlier. How much earnings per share grew versus a year earlier.
How much free cash flow does Shanghai GenTech Co Ltd (688596) generate?
The free cash flow of Shanghai GenTech Co Ltd is −169M CNY (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does Shanghai GenTech Co Ltd (688596) carry?
The net debt of Shanghai GenTech Co Ltd is 1.5B CNY (fiscal year 2025). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch Shanghai GenTech Co Ltd in the live analysis
One click puts Shanghai GenTech Co Ltd on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
